A patient with a history of anxiety and emotional instability is experiencing increased symptoms and reports frequent use of lorazepam. Her vital signs indicate possible cardiovascular strain. As a nurse, what is the most appropriate initial action to support her treatment plan?

D) Educate the patient on the benefits of cognitive-behavioral therapy (CBT) to develop healthier coping mechanisms.

A) Encourage the patient to continue the current use of lorazepam to manage acute anxiety.

B) Discuss with the healthcare provider about the potential for adjusting her fluoxetine dosage.

C) Advise the patient to increase her physical activity to naturally manage stress and anxiety.

D) Educate the patient on the benefits of cognitive-behavioral therapy (CBT) to develop healthier coping mechanisms.

A patient with a history of anxiety and emotional dysregulation is reporting increased stress and reliance on lorazepam. Her blood pressure is 150/95 mmHg, and heart rate is 110 bpm. Which nursing intervention should be prioritized to address her current condition?

C) Initiate a referral to a cognitive-behavioral therapist to develop stress management skills

A) Educate the patient on the importance of medication adherence and the risks of increased lorazepam use

B) Recommend immediate hospitalization to monitor cardiovascular status

C) Initiate a referral to a cognitive-behavioral therapist to develop stress management skills

D) Advise the patient to temporarily cease participation in the theatrical production to reduce stress

A patient with anxiety is undergoing treatment involving a slight increase in fluoxetine dosage and bi-weekly cognitive-behavioral therapy (CBT) sessions. The patient reports occasional dizziness and mild nausea, and lab results reveal mildly elevated liver enzymes. Considering these findings, what should be the priority nursing intervention?

B) Educate the patient on the potential side effects of fluoxetine and monitor liver function regularly.

A) Increase the frequency of CBT sessions to reduce the need for medication.

B) Educate the patient on the potential side effects of fluoxetine and monitor liver function regularly.

C) Encourage the patient to continue using lorazepam as needed for acute anxiety episodes.

D) Suggest the immediate discontinuation of fluoxetine to prevent further hepatic strain.

A patient with a history of anxiety is currently undergoing cognitive-behavioral therapy (CBT) and has recently had her fluoxetine dosage increased. She reports occasional dizziness and mild nausea. Her lab results show mildly elevated liver enzymes, and she continues to frequently use lorazepam. What is the most appropriate nursing intervention to address her current situation?

C) Collaborate with the healthcare team to consider transitioning the patient to a non-benzodiazepine anxiolytic.

A) Advise the patient to stop using lorazepam immediately to prevent further liver damage.

B) Educate the patient on the potential side effects of fluoxetine and suggest managing nausea with dietary changes.

C) Collaborate with the healthcare team to consider transitioning the patient to a non-benzodiazepine anxiolytic.

D) Increase the frequency of CBT sessions to reduce reliance on pharmacological interventions.

A patient being treated for anxiety with lorazepam is showing signs of hepatic strain and symptoms such as fatigue, confusion, and irritability. The healthcare team has decided to taper lorazepam and introduce buspirone. What is the primary nursing consideration when implementing this new treatment plan?

A) Monitor the patient for signs of withdrawal symptoms and educate on the gradual tapering process.

B) Assess the patient's liver function weekly to ensure the new medication is well tolerated.

C) Educate the patient about the importance of adhering to CBT sessions to mitigate anxiety symptoms.

D) Ensure the patient understands the dietary restrictions needed to support liver health.

A patient undergoing a medication adjustment presents with fatigue, confusion, irritability, tachycardia, hypertension, and jaundice. Lab results indicate elevated ALT and AST levels. Considering these symptoms and lab findings, which nursing intervention is most appropriate to address the patient's condition and prevent further complications?

B) Educate the patient on the importance of adhering to the new medication regimen including buspirone.

A) Administer lorazepam as prescribed to manage anxiety symptoms.

B) Educate the patient on the importance of adhering to the new medication regimen including buspirone.

C) Increase the frequency of CBT sessions to immediately resolve all psychological symptoms.

D) Initiate a high-protein diet to support liver function and prevent further hepatic damage.

A patient undergoing a medication adjustment from lorazepam to buspirone presents with palpitations, difficulty concentrating, and mild hyponatremia. Which of the following nursing interventions should be prioritized to address her current symptoms and ensure safe management of her anxiety?

B) Educate the patient on mindfulness-based stress reduction techniques to help manage anxiety.

A) Increase fluid intake to correct hyponatremia and continue monitoring electrolyte levels.

B) Educate the patient on mindfulness-based stress reduction techniques to help manage anxiety.

C) Administer a beta-blocker to manage tachycardia and reduce palpitations.

D) Recommend immediate cessation of buspirone to eliminate potential side effects.

A patient with anxiety disorder is transitioning from lorazepam to buspirone and presents with new symptoms of palpitations, difficulty concentrating, and mild hyponatremia. What would be the most appropriate nursing intervention to address these symptoms while considering the patient's hepatic condition?

C) Advocate for a further reduction in buspirone dosage and implement mindfulness-based stress reduction techniques.

A) Increase the buspirone dosage to better manage anxiety and reduce palpitations.

B) Encourage increased fluid intake to correct hyponatremia and monitor for improvement in concentration.

C) Advocate for a further reduction in buspirone dosage and implement mindfulness-based stress reduction techniques.

D) Suggest switching back to lorazepam to quickly alleviate anxiety and associated symptoms.

A patient with a history of histrionic personality disorder is experiencing persistent palpitations, intermittent tremor, and irritability despite adjustments in her buspirone dosage. Lab results indicate mild hypokalemia. Which nursing intervention is most appropriate to address the patient's current symptoms and lab findings?

A) Encourage increased potassium-rich foods in the diet and monitor for signs of electrolyte imbalance.

B) Recommend reducing fluid intake to prevent further dilution of electrolytes.

C) Increase the dosage of buspirone to manage anxiety symptoms more effectively.

D) Advise the patient to discontinue all medications until a cardiologist is consulted.

A patient with histrionic personality disorder on buspirone presents with persistent palpitations, intermittent tremor, and restlessness. Recent labs indicate mild hypokalemia. Which nursing intervention is most appropriate to address the patient's electrolyte imbalance while considering her current symptoms?

A) Increase dietary potassium intake through foods like bananas and spinach.

B) Administer a diuretic to manage elevated blood pressure.

C) Encourage increased fluid intake to correct electrolyte imbalances.

D) Discontinue buspirone to eliminate potential drug-induced side effects.

histrionic personality disorders - Nursing Case Study

Pathophysiology

• Primary mechanism: Histrionic personality disorder (HPD) involves dysregulation in emotional processing, potentially linked to altered neurotransmitter activity, such as serotonin and dopamine imbalances, which can affect mood and reward pathways, contributing to emotional instability and attention-seeking behaviors.

• Secondary mechanism: Dysfunctional attachment patterns during early childhood, often due to inconsistent or inadequate parental attention, may lead to a developed reliance on external validation and excessive emotional expression as a means to secure attention and approval.

• Key complication: These mechanisms can result in significant interpersonal difficulties, as individuals with HPD may struggle to maintain stable, meaningful relationships, potentially leading to increased stress and decreased overall well-being.

Patient Profile

Demographics:

35 years old, female, professional actress

History:

• Key past medical history: Diagnosed with histrionic personality disorder 5 years ago; history of anxiety; no significant physical health issues

• Current medications: Fluoxetine 20 mg daily; occasional use of lorazepam 0.5 mg for anxiety

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Intense emotional distress and interpersonal relationship issues leading to significant occupational impairment

• Key symptoms: Excessive emotionality, attention-seeking behavior, discomfort when not the center of attention, rapidly shifting and shallow expression of emotions, dramatic and theatrical mannerisms

• Vital signs: Blood pressure 140/90 mmHg, heart rate 105 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

During a routine follow-up appointment, the patient presents with increased emotional distress and reports that her interpersonal relationship issues have intensified, impacting her ability to perform at work. Upon initial assessment, the patient is visibly agitated and expresses concern about her ability to maintain her role in an upcoming theatrical production. Her excessive emotionality is evident, and she frequently shifts topics, highlighting her struggles with maintaining focus. The patient also reports a recent episode where she felt overwhelmed with anxiety, during which she took her prescribed lorazepam. However, she admits to using it more frequently than recommended in the past week due to escalating stress.

Clinically, the patient’s vital signs indicate a blood pressure of 150/95 mmHg and a heart rate of 110 bpm, suggesting increased sympathetic nervous system activity possibly linked to heightened anxiety levels. These findings raise concerns about potential cardiovascular strain if her emotional dysregulation and anxiety are not effectively managed. Furthermore, her recent reliance on lorazepam could indicate developing tolerance, necessitating a careful reassessment of her anxiety management plan. Given her role as a professional actress, her occupation places additional demands on her emotional and psychological resilience, complicating her treatment plan.

The healthcare team considers adjusting her medication regimen to better address both her anxiety and emotional instability. A possible increase in fluoxetine dosage or the introduction of cognitive-behavioral therapy (CBT) is discussed to provide her with healthier coping mechanisms and improve her ability to regulate emotions. Additionally, the team emphasizes the importance of regular monitoring for any adverse effects of medication changes, especially given her profession's high stress and her need for effective emotional modulation. The primary goal is to enhance her functioning and well-being, allowing her to maintain her professional commitments without compromising her mental health.

Section 2

Following the initial assessment, the healthcare team decides to carefully monitor the patient's response to a slight increase in her fluoxetine dosage while initiating cognitive-behavioral therapy (CBT) sessions aimed at equipping her with better stress management techniques. Over the next two weeks, the patient attends bi-weekly CBT sessions, focusing on developing healthier coping strategies for her anxiety and emotional instability. During these sessions, she learns to identify cognitive distortions and practices grounding techniques, which help her manage acute episodes of stress more effectively.

At a follow-up appointment, the patient reports a modest improvement in her ability to concentrate and a slight reduction in the frequency of her anxiety episodes. However, she mentions experiencing occasional dizziness and mild nausea, prompting the healthcare team to explore these symptoms further. Her blood pressure has stabilized to 140/90 mmHg, and her heart rate to 95 bpm, indicating a partial reduction in sympathetic nervous system activity. Despite these improvements, the patient admits to continuing her increased use of lorazepam, raising concerns about potential dependency.

The healthcare team decides to conduct a comprehensive assessment of her current medication regimen and its interactions. Lab results reveal mildly elevated liver enzymes, which could suggest early hepatic strain potentially linked to the increased lorazepam use. This finding necessitates a reevaluation of her anxiety management strategy, considering the risk of medication overuse and its physiological implications. The team discusses the possibility of introducing non-benzodiazepine anxiolytics and reinforcing CBT techniques to mitigate dependency risks while ensuring her emotional and psychological demands are sufficiently managed. This approach aims to support her professional obligations without further compromising her health, setting the stage for the next steps in her treatment journey.

Section 3

New Complications:

Following the adjustment in her treatment plan, the patient presents at her next follow-up with new symptoms that warrant immediate attention. She reports persistent fatigue, occasional episodes of confusion, and a noticeable increase in irritability. Her vital signs show a heart rate of 102 bpm and blood pressure of 150/95 mmHg, suggesting a possible rebound in sympathetic nervous system activity. Additionally, a physical examination reveals slight jaundice, prompting the healthcare team to order a liver function panel to assess the extent of hepatic involvement.

Lab results indicate a further elevation in liver enzymes, with ALT at 85 U/L and AST at 90 U/L, confirming the suspicion of hepatic strain. The combination of these findings suggests that the patient's liver may be under increased stress, potentially exacerbated by her continued lorazepam use. In light of these developments, the healthcare team prioritizes addressing the risk of benzodiazepine dependency and its implications for her liver health.

The team decides to taper the lorazepam cautiously while introducing buspirone as a non-benzodiazepine alternative to manage anxiety, reducing the potential for hepatic damage. Concurrently, the CBT sessions are intensified to enhance her coping mechanisms and support her transition away from reliance on benzodiazepines. This multifaceted approach aims to stabilize her physiological status while maintaining her ability to function professionally and personally, preparing her for the next phase of her treatment journey.

Section 4

As the treatment plan progresses with the introduction of buspirone and the tapering of lorazepam, the patient initially shows some improvement in her anxiety levels. However, during a routine follow-up, she reports new symptoms that raise concerns. She describes experiencing palpitations more frequently, especially during periods of stress, and mentions having difficulty concentrating at work. Her partner also notes that she seems more withdrawn and less expressive, which is a departure from her typically vibrant personality. Upon examination, her vital signs reveal a persistent tachycardia with a heart rate of 110 bpm and slightly elevated blood pressure at 145/92 mmHg.

These symptoms prompt the healthcare team to consider the possibility of buspirone inducing side effects such as increased heart rate and the challenge of managing her anxiety without exacerbating her hepatic condition. To address these concerns, the team orders an ECG to evaluate cardiac function and checks her electrolytes to rule out any imbalances contributing to her symptoms. The ECG comes back normal, but her electrolyte panel reveals a mild hyponatremia with sodium levels at 132 mEq/L, which could explain some of her confusion and concentration difficulties.

In light of these findings, the healthcare team decides to adjust her medication regimen further by slightly reducing the buspirone dosage and monitoring her electrolyte levels more closely. They also explore additional non-pharmacological interventions, such as mindfulness-based stress reduction, to provide her with more tools to manage anxiety without relying solely on medication. This approach aims to balance her mental health needs with her physical well-being, highlighting the importance of interdisciplinary coordination and careful monitoring in managing complex cases like hers.

Section 5

As the healthcare team continues to monitor the patient, they notice a subtle yet significant change in her status over the next few weeks. Despite the adjustment in her buspirone dosage, the patient reports persistent palpitations and a newly developed intermittent tremor, particularly noticeable in her hands. These symptoms are accompanied by a persistent sense of restlessness and irritability, causing concern for potential drug-induced side effects or another underlying condition. Her partner also mentions that she has become increasingly forgetful, often misplacing items or struggling to recall recent conversations, further complicating her ability to function effectively at work.

During a follow-up appointment, her vital signs reveal a slight improvement in heart rate, now at 102 bpm, but her blood pressure remains elevated at 148/94 mmHg. The persistence of tachycardia and heightened blood pressure prompts the team to delve deeper into potential causes. A repeat electrolyte panel shows that her sodium levels have improved slightly to 134 mEq/L, but new findings indicate a mild hypokalemia with potassium levels at 3.2 mEq/L. The combination of these symptoms and lab results raises suspicion of a possible interaction between her medications and her body's electrolyte balance.

The team decides to implement a more comprehensive intervention strategy. This involves consulting a cardiologist to rule out any cardiac complications and collaborating with a dietitian to address her electrolyte imbalances through dietary modifications. They also emphasize the importance of adherence to mindfulness practices introduced earlier, as these techniques offer a non-pharmacological means of reducing her anxiety and improving her concentration. The interdisciplinary approach underscores the complexity of managing her histrionic personality disorder with concurrent physical symptoms, ensuring a holistic approach to her care.